HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Cefoxitin

HCID 441199
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
35607-66-0
Standard SMILES
CO[C@@]1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@@H]21
InChIKey
WZOZEZRFJCJXNZ-ZBFHGGJFSA-N
Molecular formula
C16H17N3O7S2
Average molar mass
427.5 g/mol
Monoisotopic mass
427.05079224

Overview

Cefoxitin is a semisynthetic cephamycin antibiotic which, in addition to the methoxy group at the 7alpha position, has 2-thienylacetamido and carbamoyloxymethyl side-groups. It is resistant to beta-lactamase. It has a role as an antibacterial drug. It is a cephalosporin, a cephamycin, a semisynthetic derivative and a beta-lactam antibiotic allergen. It is a conjugate acid of a cefoxitin(1-).

Names & identifiers

Preferred name
Cefoxitin
IUPAC
(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
English name
Cefoxitin
Molecular formula
C16H17N3O7S2
Molecular weight
427.45

Names & synonyms

cefoxitin35607-66-0CefoxitinaCefoxitineCEPHOXITINCefoxitinumRephoxitinMefoxitinCenomycinceftoxitinDTXSID10227646OEV9DX57Y
Show more names
cfxCEFOXITIN ACIDC06887MefoxinCefotaxidineCefoxitinic acid
J01DC01CHEBI:209807(6R,7S)-3-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[2-(thiophen-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidDTXCID002764(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidMK306MK 306(6R,7S)-3-((carbamoyloxy)methyl)-7-methoxy-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Database identifiers

CAS
35607-66-0
PubChem CID
441199
DTXSID
DTXSID1022764
ChEMBL
CHEMBL996
ChEBI
CHEBI:209807
UNII
6OEV9DX57Y
EC Number
252-641-2

Properties

Computed structural propertiesFilling in

XLogP
0
Topological polar surface area
202 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
9
Rotatable bonds
8
Heavy atoms
28
Formal charge
0
Complexity
744

Experimental & physicochemical properties

Drugs · 3 items

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Listed in ZINC15

LogP · 2 items

-0.02

-0.02

Solubility1.95e-01 g/L
Human DrugsBreast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Cephalosporins
Melting Point · 2 items

165-167

149.5 °C

Physical DescriptionSolid
Collision Cross Section180.82 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
149 · 149-150℃

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 66.7% (2 of 3) of all reports.

Danger

H317 (33.3%): May cause an allergic skin reaction [Warning Sensitization, Skin]

P233, P260, P261, P271, P272, P280, P284, P302+P352, P304+P340, P321, P333+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory InformationREACH registered substance: Cefoxitin (EC: 252-641-2)
Other Safety InformationIMAP assessments - 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-, (6R-cis)-: Environment tier I assessment
Hazard Classes and CategoriesSkin Sens. 1 (33.3%)

Toxicology

Drug Induced Liver Injury · 5 items

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

cefoxitin

DILI Negative

Intravenous

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Safety data

Chemistry & industry

Pharmacology

ATC Code · 2 items

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

Pharmacodynamics · 1 item

Cefoxitin is a cephamycin antibiotic often grouped with the second-generation cephalosporins. It is active against a broad range of gram-negative bacteria including anaerobes. The methoxy group in the 7a position provides cefoxitin with a high degree of stability in the presence of beta-lactamases, both penicillinases and cephalosporinases, of gram-negative bacteria.

Mechanism of ActionThe bactericidal action of cefoxitin results from inhibition of cell wall synthesis.
Biological Half-LifeThe half-life after an intravenous dose is 41 to 59 minutes.
Metabolism/MetabolitesMinimal (approximately 85 percent of cefoxitin is excreted unchanged by the kidneys over a 6-hour period).
FDA Pharmacological Classification · 6 items

6OEV9DX57Y

CEFOXITIN

Established Pharmacologic Class [EPC] - Cephalosporin Antibacterial

Chemical Structure [CS] - Cephalosporins

Cefoxitin is a Cephalosporin Antibacterial.

CEFOXITIN

MeSH Pharmacological ClassificationSubstances that inhibit the growth or reproduction of BACTERIA.
Absorption, Distribution and Excretion · 1 item

Approximately 85 percent of cefoxitin is excreted unchanged by the kidneys over a 6-hour period, resulting in high urinary concentrations. Cefoxitin passes into pleural and joint fluids and is detectable in antibacterial concentrations in bile.

Cellular LocationsExtracellular

Related reactions

1 records
New reaction record
HRID 1444658 reaction equation
HRID 1444658As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Nikkaji
J17.441F
Boiling point
843 ℃ · 843℃
Density
1.4441 · 1.4441 (rough estimate)
refractive index
1.639 · 1.6390 (estimate)
RTECS
386500 · XI0386500
Flash point
110 ° · >110°(230°F)
storage temp.
2 · 2-8°C
solubility
DMSO (Slightly), Methanol (Slightly)
form
Solid
pka
2.2 · 2.2(at 25℃)
color
White to Off-White
Water Solubility
0.2 mg/ml · Predicted solubility in water is less than 0.2mg/ml
InChIKey
WZOZEZRFJCJXNZ-ZBFHGGJFSA-N
SMILES
N12[C@@]([H])([C@](OC)(NC(CC3SC=CC=3)=O)C1=O)SCC(COC(N)=O)=C2C(O)=O
CAS DataBase Reference
35607 · 35607-66-0(CAS DataBase Reference)
FDA UNII
6 OEV9DX57Y · 6OEV9DX57Y
NCI Drug Dictionary
Mefoxin
ATC code
1 DC01 · J01DC01
EPA Substance Registry System
Cefoxitin (35607-66-0)
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
317 · H317
Precautionary statements
261 · P261-P280g-P302+P352a-P321-P333+P313-P501a
RIDADR
3077 · 3077
HazardClass
9 · 9
PackingGroup
III
HS Code
30032013 · 30032013
REACH Registrations
Active
ridadr
3077
hs_code
30032013
Signal word
Warning
Symbol(GHS)
GHS07
hazard_class
9
packing_group
III
Hazard statements
H317
REACH Registrations
Active
Precautionary statements
P261-P280g-P302+P352a-P321-P333+P313-P501a

Uses & manufacturing

UsesUse (kg) in USA (2002): 2700
Applications · 3 items

DescriptionCefoxitin contains the same C-7 side chain as cephalothin and the same C-3 side chain as cefuroxime. The most novel chemical feature of cefoxitin is the possession of an α-oriented methoxyl group in place of the normal H-atom at C-7. This increased steric bulk conveys very significant stability against β-lactamases. The inspiration for these functional groups was provided by the discovery of the naturally occurring antibiotic cephamycin C derived from fermentation of Streptomyces lactamdurans. Cephamycin C itself has not seen clinical use but, rather, has provided the structural clue that led to useful agents such as cefoxitin. Agents that contain this 7α methoxy group are commonly referred to as cephamycins. Ingenious chemical transformations now enable synthetic introduction of such a methoxy group into cephalosporins lacking this feature.

UsesCefoxitinis a semisynthetic, broad-spectrum second-generation cephalosporin with antibacterial activity. The activity of cefoxitin results in the weakening of the bacterial cell wall and causes cell lysis. Cefoxitin acts by interfering with cell wall synthesis. Its activity spectrum includes a broad range of gram-negative and gram-positive bacteria including anaerobes.

UsesAntibacterial.

Upstream & downstream products

Upstream raw materials

Dimethyl sulfateSodium hydrideTrifluoroacetic acid(6R-cis)-3-(acetoxymethyl)-7-methoxy-8-oxo-7-(2-thienylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidCephalothindeacetylcephalosporin CChlorosulfonyl isocyanate2-Thiopheneacetyl chloride7-Aminocephalosporanic acid
Additional notes · 1 item

DefinitionChEBI: Cefoxitin is a semisynthetic cephamycin antibiotic which, in addition to the methoxy group at the 7alpha position, has 2-thienylacetamido and carbamoyloxymethyl side-groups. It is resistant to beta-lactamase. It has a role as an antibacterial drug. It is a cephalosporin, a semisynthetic derivative, a beta-lactam antibiotic allergen and a cephamycin. It is a conjugate acid of a cefoxitin(1-).